UNH stock wobbles as UnitedHealth releases first external audit results, here’s why the 23 action plans might not save the healthcare giant

UNH stock showed volatility on Friday, December 19, 2025, as UnitedHealth Group released the first results from its independent external audits and committed to 23 sweeping action plans to address operational improvements. The announcement marks CEO Stephen Hemsley’s most significant transparency move since returning to lead the troubled healthcare giant in May 2025.

External Audits Reveal Compliance Gaps Across UnitedHealth Operations

FTI Consulting examined UnitedHealthcare’s Medicare Advantage risk assessment practices and care services management processes, finding issues with standardized documentation in programs like HouseCalls.

The review revealed that slow decision-making on member authorizations and inadequate handling of regulatory audit findings represented areas needing improvement. Notably, FTI did not evaluate legal compliance matters, dodging the elephant in the room: ongoing Department of Justice investigations into Medicare Advantage billing practices.

Separately, Analysis Group assessed OptumRx’s pharmacy benefit manager operations, reviewing how the company collects and distributes manufacturer discounts to clients. The analysis found existing controls were comprehensive but identified opportunities for process enhancement.

23-Point Action Plan Targets Automation and Standardization for Early 2026

CEO Hemsley stated Friday that “several action plans have already been completed” and pledged aggressive implementation timelines. More than half of the remaining actions will reach completion before year-end 2025, with full implementation by March 31, 2026.

The action plans emphasize increased automation, centralized documentation policies, and enhanced standardization across business units. Among specific initiatives, UnitedHealth will develop formal policies for addressing nonpayment and dispute cases in its PBM operations and strengthen escalation procedures with pharmaceutical manufacturers.

For Medicare Advantage operations, improvements target better alignment with regulatory audit recommendations and faster authorization processing. HouseCalls visit review results will be shared during the first quarter of 2026, delaying transparency on a particularly sensitive program.

Area of Review	Finding	Timeline
Medicare Advantage Risk Assessment	Documentation gaps, slow authorizations	By March 2026
OptumRx Discount Controls	Strong framework, process enhancements needed	By March 2026
HouseCalls Program Review	Pending detailed assessment	Q1 2026
Medical Policy Evidence	Process standardization in progress	Mid-2026

Can UnitedHealth Rebuild Trust Amid Ongoing DOJ Scrutiny?

The audit announcement arrives as UnitedHealth faces criminal and civil Department of Justice investigations into potential Medicare Advantage billing improprieties. The external review appears carefully calibrated to address operational deficiencies without acknowledging legal exposure.

Hemsley framed the transparency initiative as setting “a new standard for the health care marketplace,” yet the timing and scope raise questions about sincerity. The audits examined business processes but explicitly excluded legal compliance evaluation, limiting their investigative firepower precisely where regulators are focusing scrutiny.

Investors watching UNH stock remain wary: the company’s stock price has fallen more than 35% in 2025 following a brutal April earnings miss, CEO succession, and public backlash following UnitedHealthcare executive Brian Thompson’s assassination. Whether operational improvements can restore confidence remains uncertain.

“We know that our actions and decisions have significant impacts on patients, care providers and the broader health system, and we are determined to hold ourselves to the highest standard.”

— Stephen Hemsley, CEO of UnitedHealth Group

What Does the Wobble in UNH Stock Tell Us About Market Confidence?

UnitedHealth’s stock movement Friday reflected cautious uncertainty rather than enthusiastic recovery. While the audit results offered reassurance that internal operations are “generally sound,” they failed to address the core crisis facing the company: soaring medical costs and deteriorating profit margins that triggered its unprecedented spring collapse.

The 23-action roadmap until March 2026 represents legitimate operational housekeeping but sidesteps the fundamental financial challenges that triggered massive earnings cuts. Until medical care ratios improve and the DOJ investigations conclude, UNH stock faces structural headwinds regardless of internal process improvements.

Analysts note that completing 65% of action plans by year-end 2025 requires sophisticated execution during the critical holiday season when healthcare utilization typically spikes. Any implementation delays could signal deeper operational challenges than the audits acknowledged.

---

Sources

• Reuters – UnitedHealth pledges operational changes after external audits
• CNBC – UnitedHealth Group commits to improvements after independent audit
• Becker’s Payer Issues – UnitedHealth releases company-wide policy audit report